CA-XPRIZE
10.11.2021 13:02:13 CET | Business Wire | Press release
XPRIZE , the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges, today announced that 23 student-led teams have won the $5M Carbon Removal Student Competition . The award program, which is part of the $100 Million XPRIZE for Carbon Removal supported by the Musk Foundation , was launched, in part, to fund early stage concepts from the next generation of carbon removal innovators and to remove barriers to entry for those interested in the main competition.
Competing student teams had the opportunity to submit their concepts for an award in one of two tracks, Carbon Dioxide Removal Demonstrations or Measurement, Reporting, and Verification Technologies . Winning student teams are able to use funds to compete in subsequent rounds of XPRIZE Carbon Removal or to develop key supporting technologies which will enable carbon dioxide removal. Points of focus for the two award tracks were as follows:
- Carbon Dioxide Removal Demonstrations: Awards of US$250,000 to student teams intending to compete for the XPRIZE Carbon Removal Milestone and Grand Prize awards across the various carbon removal pathways: Air, Land, Rocks, Oceans. Teams needed to convince the judges that their proposed carbon removal projects would make them competitive applicants in the overall competition. This was the main focus of the Student Awards; the majority of awards are in this category.
- Measurement, Reporting, and Verification Technologies : Awards of US$100,000 for the development of technologies that may not directly remove CO2 , but will enable carbon removal. Technologies or methodologies for improving the standards of assessment, or the precision, accuracy, and time required for carbon measurements were considered.
Representing ten countries and 31 international educational institutions, the winners of the Carbon Removal Student Competition, included:
Student Carbon Removal Demonstrations:
- Answer of Biochar (AOB) from Northeastern University, China (China)
- E-quester from the University of Toronto (Canada)
- BioCORE from the University of Munich (Germany)
- Biosorra from IESE Business School and the Fuqua School of Business (Spain & United States)
- Bison Underground affiliated with the University of Oklahoma (United States)
- Blue Symbiosis from the University of Tasmania IMAS AMC (Australia)
- C2 (C-Squared) from Virginia Tech and the Max Planck Institute for Biogeochemistry (Germany & United States)
- Carbon Down Under from Southern Illinois University, Carbondale (United States)
- CyanoCapture from the University of Oxford (United Kingdom)
- Holocene Climate from Stanford University (United States)
- KFC from Hohai University , Tianjin University , Shanghai Ocean University , and Chinese Academy of Fishery Sciences (China)
- Mississippi State Energy Club - BECReative Energy from Mississippi State University (United States)
- Monash Carbon Capture and Conversion (BioTech) from Monash University (Australia & Malaysia)
- SASIITB from Indian Institute of Technology, Bombay (India)
- Skyrenu Technologies from Université De Sherbrooke and Inrs-Eau Terre Environnement Research Centre (Canada)
- Sydney Sustainable Carbon from the University of Sydney (Australia)
- Takachar (Safi Organics) from the University of British Columbia , Northeastern University and IISC Bangalore (Canada, India, Kenya & United States)
- UW-Madison Civil and Environmental Engineering from the University of Wisconsin, Madison (United States)
Measurement, Reporting, and Verification Technologies:
- ACIDD Project from the University of Miami (United States)
- BJU Global Challenges from Bob Jones University (United States)
- Environmental Sensing from the University of Wyoming (United States)
- PlantVillage from Pennsylvania State University (United States)
- Working Trees from Stanford University (United States)
In order to be eligible for the Carbon Removal Student Competition , student teams needed at least 50% of their members to be currently enrolled in an educational institution with the support of an academic advisor or business leader able to act as a formal mentor. All submissions were reviewed by a panel of expert third-party judges who considered the innovation, ability to reach gigaton scale, team resources and capabilities as well as project plan feasibility in their selection process.
“We want to make a truly meaningful impact. Carbon negativity, not neutrality. The ultimate goal is scalable carbon extraction technologies that are measured based on the ‘fully considered cost per ton’ which includes the environmental impact. This is not a theoretical competition; we want teams that will build real systems that can make a measurable impact and scale to a gigaton level. Whatever it takes. Time is of the essence,” said Elon Musk, Founder and CEO of Tesla and SpaceX , in a previous statement.
Launched in April, XPRIZE Carbon Removal is a US$100M four-year global competition that invites innovators and teams from anywhere on the planet to create and demonstrate solutions that can pull carbon dioxide directly from the atmosphere or oceans. To win the grand prize, teams must demonstrate a working solution at a scale of at least 1000 tonnes removed per year; model their costs at a scale of 1 million tonnes per year; and show a pathway to achieving a scale of gigatonnes per year in future, as validated by a third party.
“Today’s college and graduate students have proclaimed that solving the climate crisis is one of the most important objectives of their generation. It’s for this reason that this student competition is so critical. Our mission is to engage, inspire and guide the next generation of climate entrepreneurs,” said Peter H. Diamandis, Founder and Executive Chairman of XPRIZE .
Any carbon negative solution is eligible: nature-based, direct air capture, oceans, mineralization, or anything else that achieves net negative emissions, sequesters CO2 durably, and shows a sustainable path to ultimately achieving gigatonne scale.
“The climate crisis is an existential threat that demands both immediate action, and a long-term commitment to bringing Earth’s carbon cycle back into balance for future generations,” said Dr. Marcius Extavour, Vice President of Climate and Environment at XPRIZE . “We’ve already begun to feel the impacts of the climate crisis in our day-to-day lives, and the data shows us that we need both immediate action on emissions reductions, and sustained innovation to develop additional tools like carbon removal. That’s why this prize is so important. It’s about mobilizing and facilitating the development of scalable solutions that can make a real difference in stabilizing the climate over the coming decades.”
For more information on XPRIZE Carbon Removal , to view the prize guidelines or to register, please visit xprize.org/carbonremoval .
About XPRIZE
XPRIZE is a global future-positive movement of over 1M people and rising, delivering truly radical breakthroughs for the benefit of humanity. XPRIZE inspires and empowers a global community of problem-solvers to positively impact our world by crowdsourcing solutions through large-scale competitions, tackling the world’s grandest challenges in exploration, environment and human equity. Active competitions include the $100 Million XPRIZE Carbon Removal with Elon Musk, $15 Million XPRIZE Feed the Next Billion, $10 Million XPRIZE Rainforest, $10 Million ANA Avatar XPRIZE, $5 Million XPRIZE Rapid Reskilling and $1 Million Digital Learning Challenge. Donate, sign up or join a team at xprize.org.
About The Musk Foundation
The Musk Foundation creates grants made in support of: renewable energy research and advocacy; human space exploration research and advocacy; pediatric research; science and engineering education; and development of safe artificial intelligence to benefit humanity.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005384/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
